Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,031.04 +12.65 (+0.25%) Dow
38,037.36 +134.07 (+0.35%) Nasdaq
15,690.86 +85.38 (+0.55%) Bitcoin USD
59,028.59 +1,699.86 (+2.97%) CMC Crypto 200
1,269.67 -1.07 (-0.08%)
10x Genomics, Inc. (TXG)
| Previous close | 26.92 |
| Open | 27.52 |
| Bid | 26.06 x 200 |
| Ask | 26.17 x 200 |
| Day's range | 25.60 - 27.58 |
| 52-week range | 24.60 - 63.57 |
| Volume | |
| Avg. volume | 1,564,480 |
| Market cap | 3.126B |
| Beta (5Y monthly) | 1.89 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
10x Genomics Reports First Quarter 2024 Financial Results
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2024.
- PR Newswire
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report financial results for the first quarter ended March 31, 2024 after market close on Tuesday, April 30, 2024. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible fro
- PR Newswire
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Visium HD Spatial Gene Expression product. This assay enables researchers to measure the whole transcriptome from FFPE tissue sections at single cell-scale resolution.
